Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors
Clinical trial NCT07327411 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07327411
- Sponsor
- Second Affiliated Hospital of Soochow University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-27
- Primary completion
- 2027-02-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.